
It has long had technology to rival chatbots like ChatGPT, but can’t afford to back artificial intelligence that can spread misinformation and toxic content.
When Dan Heller received his first batch of Dexcom’s latest continuous glucose monitors in early 2023, he decided to run a small experim...
No comments:
Post a Comment